201 related articles for article (PubMed ID: 27170300)
21. Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial.
Nenke MA; Haylock CL; Rankin W; Inder WJ; Gagliardi L; Eldridge C; Rolan P; Torpy DJ
Psychoneuroendocrinology; 2015 Jun; 56():157-67. PubMed ID: 25827960
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid replacement therapy for primary and secondary adrenal insufficiency and their impact on cognition.
Harbeck B; Kropp P; Kreitschmann-Andermahr I
Front Endocrinol (Lausanne); 2023; 14():1153595. PubMed ID: 37008924
[TBL] [Abstract][Full Text] [Related]
23. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
[TBL] [Abstract][Full Text] [Related]
24. Mild cognitive deficits in patients with primary adrenal insufficiency.
Tiemensma J; Andela CD; Biermasz NR; Romijn JA; Pereira AM
Psychoneuroendocrinology; 2016 Jan; 63():170-7. PubMed ID: 26454105
[TBL] [Abstract][Full Text] [Related]
25. Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients.
Delle Cese F; Corsello A; Cintoni M; Locantore P; Pontecorvi A; Corsello SM; Paragliola RM
Front Endocrinol (Lausanne); 2020; 11():610904. PubMed ID: 33597926
[TBL] [Abstract][Full Text] [Related]
26. Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.
Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Ragnarsson O; Skrtic S; Wahlberg J; Achenbach H; Uddin S; Marelli C; Johannsson G
Eur J Endocrinol; 2017 Jun; 176(6):715-725. PubMed ID: 28292927
[TBL] [Abstract][Full Text] [Related]
27. Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review.
Caetano CM; Malchoff CD
Front Endocrinol (Lausanne); 2022; 13():897211. PubMed ID: 35846313
[TBL] [Abstract][Full Text] [Related]
28. GLUCOCORTICOID REPLACEMENT REGIMENS IN CHRONIC ADRENAL INSUFFICIENCY: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Al Nofal A; Bancos I; Benkhadra K; Ospina NM; Javed A; Kapoor E; Muthusamy K; Brito JP; Turcu AF; Wang Z; Prokop L; Erickson DZ; Lteif AN; Natt N; Murad MH
Endocr Pract; 2017 Jan; 23(1):17-31. PubMed ID: 27631672
[TBL] [Abstract][Full Text] [Related]
29. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
Murray RD; Ekman B; Uddin S; Marelli C; Quinkler M; Zelissen PM;
Clin Endocrinol (Oxf); 2017 Mar; 86(3):340-346. PubMed ID: 27801983
[TBL] [Abstract][Full Text] [Related]
30. Is physiological glucocorticoid replacement important in children?
Porter J; Blair J; Ross RJ
Arch Dis Child; 2017 Feb; 102(2):199-205. PubMed ID: 27582458
[TBL] [Abstract][Full Text] [Related]
31. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.
Debono M; Ross RJ; Newell-Price J
Eur J Endocrinol; 2009 May; 160(5):719-29. PubMed ID: 19168600
[TBL] [Abstract][Full Text] [Related]
32. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
Ekman B; Fitts D; Marelli C; Murray RD; Quinkler M; Zelissen PM
BMC Endocr Disord; 2014 May; 14():40. PubMed ID: 24884782
[TBL] [Abstract][Full Text] [Related]
33. Self-management in adrenal insufficiency - towards a better understanding.
Kampmeyer D; Haas CS; Moenig H; Harbeck B
Endocr J; 2017 Apr; 64(4):379-385. PubMed ID: 28190868
[TBL] [Abstract][Full Text] [Related]
34. Improving glucocorticoid replacement profiles in adrenal insufficiency.
Choudhury S; Lightman S; Meeran K
Clin Endocrinol (Oxf); 2019 Sep; 91(3):367-371. PubMed ID: 31017681
[TBL] [Abstract][Full Text] [Related]
35. Increased Hair Cortisol Concentrations and BMI in Patients With Pituitary-Adrenal Disease on Hydrocortisone Replacement.
Staufenbiel SM; Andela CD; Manenschijn L; Pereira AM; van Rossum EF; Biermasz NR
J Clin Endocrinol Metab; 2015 Jun; 100(6):2456-62. PubMed ID: 25816049
[TBL] [Abstract][Full Text] [Related]
36. Increased Cardiovascular Risk in Patients with Adrenal Insufficiency: A Short Review.
Rahvar AH; Haas CS; Danneberg S; Harbeck B
Biomed Res Int; 2017; 2017():3691913. PubMed ID: 29376070
[TBL] [Abstract][Full Text] [Related]
37. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
[TBL] [Abstract][Full Text] [Related]
38. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
Lennernäs H; Skrtic S; Johannsson G
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
[TBL] [Abstract][Full Text] [Related]
39. An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.
Castinetti F; Sahnoun M; Albarel F; Morange I; Philippon M; Conte-Devolx B; Brue T
Ann Endocrinol (Paris); 2015 Feb; 76(1):1-8. PubMed ID: 25617904
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.
Alonso N; Granada ML; Lucas A; Salinas I; Reverter J; Oriol A; Sanmarti A
J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
